Global Fund postpones Round 11 grants, approves new strategy and organization plan

The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria decided to postpone Round 11 grant approval during a two-day meeting in Accra, Ghana, that concluded on November 22. According to a press release from the Global Fund, the decision to postpone Round 11 was due to "a revised resource forecast presented to the Board [which] showed that substantial budget challenges in some donor countries, compounded by low interest rates, have significantly affected the resources available for new grant funding."

Additional decisions made by the Board included the approval of a new five-year strategy, the adoption of a plan with the aim "to improve its risk management, fiduciary controls and governance," and the appointment of "a General Manager to work alongside the Executive Director" to "help to take the organization through its transformation phase over the next 12 months" (11/23).

Additional coverage of the board meeting was provided by the Guardian, the Globe and Mail, the Associated Press/CBS News, the Washington Post, IRIN, GlobalPost, International Business Times, Reuters, Bloomberg, and the New York Times.


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough discovery could lead to novel malaria vaccines and therapies